Home
LiteratureArticle Details
PMID: 9717955
Published · ppublish
English
Comment
Letter
Tamoxifen in early breast cancer.
Abstract
暂无摘要
MeSH Terms
Anticarcinogenic Agents/therapeutic use
Antineoplastic Agents, Hormonal/therapeutic use
Breast Neoplasms/drug therapy,pathology,prevention & control
Chemotherapy, Adjuvant
Disease Progression
Estrogen Antagonists/therapeutic use
Female
Humans
Neoplasm Recurrence, Local
Precancerous Conditions/pathology,prevention & control
Receptors, Estrogen/analysis
Survival Rate
Tamoxifen/therapeutic use
Transforming Growth Factor beta/analysis
Chemicals
Anticarcinogenic Agents
Antineoplastic Agents, Hormonal
Estrogen Antagonists
Receptors, Estrogen
Transforming Growth Factor beta
Tamoxifen
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
Published
1998-08-01
Pages
404-5
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Corrections
CommentOn
Analysis Services
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
